関連する実験動画
Updated: Jan 10, 2026
01:27
Disorders of Erythrocytes
2.0K
SMAD4依存性バリアは,前立腺がんの成長と転移進行を抑制する
Zhihu Ding1, Chang-Jiun Wu, Gerald C Chu
1Belfer Institute for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA.
Nature
|February 4, 2011
まとめ
マウスの前立腺腫瘍におけるSMAD4の不活性化により,進行と転移が加速されます. PTENとSMAD4を含む4つの遺伝子シグネチャは,ヒト前立腺がんの再発と致死性転移を予測する.
科学分野:
- 腫瘍学 腫瘍学
- 遺伝学 遺伝学とは
- 分子生物学は分子生物学である.
背景:
- 前立腺がん (PCA) の管理は,異質性や進行要因の理解が不十分で妨げられています.
- マウスモデルは,PCAの進行を制御する遺伝的要素の調査に不可欠です.
研究 の 目的:
- 進行を抑制する経路が,不活性なPten-nullマウス前立腺腫瘍で活性化されているかどうかをテストする.
- マウスの進行障壁の無効化が転移につながるかどうかを判断する.
主な方法:
- 正常対Pten-null前立腺上皮質のトランスクリプトミクスと経路の比較分析.
- Pten-nullマウスのSmad4の遺伝子削除.
- 新興腫瘍の病理学的,分子的,およびトランスクリプトミックのプロフィール作成.
主要な成果:
- Pten-null前立腺がんは,TGFβ/BMP-SMAD4シグナル伝達軸の強力な活性化を示した.
- Pten-nullマウスのSmad4の遺伝子削除は,100%の浸透率で侵襲性,転移性,致命的なPCAにつながりました.
- 細胞増殖と侵入は,サイクリンD1とSPP1.1によって媒介される転移性Smad4/Pten-null PCAモデルにおける重要な特徴として特定されました.
結論:
- SMAD4は,マウスとヒトのPCA進行の重要なレギュラーです.
- 4つの遺伝子シグネチャー (PTEN,SMAD4,サイクリンD1,SPP1) は,ヒトPCAにおけるPSA再発と致死性転移の予後である.
関連する概念動画
Acute Kidney Injury IV: Diagnostic Studies and Prevention
249
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
249
Disorders of Erythrocytes
2.0K
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
2.0K
Blood Transfusion and Agglutination
14.0K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
14.0K
Rh Blood Group
2.7K
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
2.7K
Blood Transfusion
2.1K
Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
2.1K
Blood Typing
2.3K
Understanding an individual's blood group is a critical component of transfusion medicine. It ensures compatibility in blood transfusions, organ transplants, and even during pregnancy. Determining these blood groups involves the ABO and Rh blood typing systems, utilizing specific antigens and corresponding anti-sera to identify an individual's blood type.
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target...
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target...
2.3K